Latest news with #Arni
Business Standard
11-08-2025
- Business
- Business Standard
Sri Lakshmi Saraswathi Textiles (Arni) reports standalone net loss of Rs 3.77 crore in the June 2025 quarter
Sales decline 5.54% to Rs 21.98 croreNet Loss of Sri Lakshmi Saraswathi Textiles (Arni) reported to Rs 3.77 crore in the quarter ended June 2025 as against net loss of Rs 6.19 crore during the previous quarter ended June 2024. Sales declined 5.54% to Rs 21.98 crore in the quarter ended June 2025 as against Rs 23.27 crore during the previous quarter ended June EndedJun. 2025Jun. 2024% -6 OPM %-9.37-18.91 -PBDT-3.35-5.75 42 PBT-3.77-6.19 39 NP-3.77-6.19 39 Powered by Capital Market - Live News
Business Standard
24-05-2025
- Business
- Business Standard
Sri Lakshmi Saraswathi Textiles (Arni) reports standalone net loss of Rs 4.39 crore in the March 2025 quarter
Sales decline 7.49% to Rs 26.18 crore Net Loss of Sri Lakshmi Saraswathi Textiles (Arni) reported to Rs 4.39 crore in the quarter ended March 2025 as against net loss of Rs 4.03 crore during the previous quarter ended March 2024. Sales declined 7.49% to Rs 26.18 crore in the quarter ended March 2025 as against Rs 28.30 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 21.32 crore in the year ended March 2025 as against net loss of Rs 19.98 crore during the previous year ended March 2024. Sales declined 21.70% to Rs 99.54 crore in the year ended March 2025 as against Rs 127.12 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 26.1828.30 -7 99.54127.12 -22 OPM % -13.48-10.85 - -14.42-11.02 - PBDT -3.76-3.55 -6 -19.32-18.05 -7 PBT -4.21-4.03 -4 -21.14-19.98 -6 NP -4.39-4.03 -9 -21.32-19.98 -7
New Straits Times
15-05-2025
- Business
- New Straits Times
Petronas poised to help accelerate Asian energy transition
KUALA LUMPUR: Petroliam Nasional Bhd (Petronas) is set to strengthen its role in accelerating the regional energy transition by hosting the second edition of Energy Asia 2025 from June 16. The three-day conference here aims to serve as a high-level platform, bringing together global energy leaders to deliberate on collaborative strategies for achieving a sustainable energy future across Asia — and, by extension, the world. Petronas vice president of group strategic relations and communications Ir Norafizal Mat Saad said the event underscores the company's long-term commitment to fostering regional cooperation and catalysing collective progress toward a more inclusive and comprehensive energy transition. "Energy Asia is about how Petronas play a role in bringing together the agenda of energy transition for Asia. This is where the leaders from all over the world will come and convene. "Hopefully this kind of session will further drive and collaborate the energy transition efforts throughout Asia and which has also impacted the world," he told a press conference at Petronas Lunch Escape: Road to Energy Asia here today. Petronas gathered nearly 100 media and communications professionals from over 30 organisations for a lunch talk titled 'Road to Energy Asia 2025', aiming to build momentum ahead of its flagship energy conference next month. The session offered a preview of the upcoming Energy Asia 2025. Energy Asia 2025 will feature more than 180 global speakers and is expected to draw over 4,000 delegates from 50 countries. Its programme includes over 50 strategic dialogues under themes such as energy policy, markets, innovation, capital, sustainability and talent development. Petronas senior general manager and strategy, planning and governance Datin Arni Laily Anwarrudin said the efforts to strengthen Energy Asia are being continued annually, particularly with the second edition this year focusing on expanding the programme's reach and impact. Arni said this year, in addition to the chief executive officer (CEO) roundtable session, Petronas is also introducing and enhancing the Future Energy Leaders programme, which targets the younger generation. "This initiative aims to cultivate a new generation that is not only interested but also committed to participating in the energy transition agenda. "The programme is also designed to create a more holistic ecosystem by exposing young talent to opportunities within the evolving energy transition landscape," she added. Meanwhile, Arni said the Energy Park, a core component of the event, will be revamped this year, expanding to two to three times the size of the 2023 edition and showcasing a more immersive blend of technology and innovation. She said curating the right mix of participants is central to the event's mission. "The target that has been set for us goes beyond numbers. It is about getting the right mix of delegates. One of the things we are very deliberate about is ensuring we bring together policymakers, academicians, C-suites, founders, tech experts, innovators, and energy companies. "We don't just want decision-makers and executives in the room, but we want young people, emerging leaders, and diverse voices who will actually be part of the transition. More women representation is also a key consideration," she added.
Time of India
08-05-2025
- Health
- Time of India
‘Pharmacology, healthy lifestyle only recourse to treating heart failure'
The coronary arteries supply blood to the heart. The heart squeezes blood by 'pumping' it to every nook and corner of the body. If blood flow gets suddenly interrupted owing to a blockage, you get an acute heart attack — myocardial infarction. But if the pump slackens, that is if the specialized myocardial muscles get enfeebled, in patches or as a whole, this is heart death results from a massive blockade, but heart failure can be in different grades from mild to severe and presents with varying degrees of need to appreciate that angioplasty and bypass are mechanical procedures to amend the circulation, but the treatment to heart failure is purely pharmacological and healthy chronic heart failure is a debilitating, symptomatic condition which repeatedly brings the patient to emergency, and except for juggling with drugs, there is little to tragic story of heart failure (measured on an echocardiogram as a reduction in ejection fraction (EF)), is that the first attack often is a signal of many events to come, which could successively dampen and worsen heart heart muscle of the ventricles contract and relax in symphony in a rhythmic fashion to eject blood. If this orchestra of the normal muscles is disrupted, then that segment of the limping ventricle gets handicapped and is unable to push out the blood from the following a heart attack, even after healing, the specialised heart muscle in the injured area gets replaced by fibrous not contractile tissue, which then results in inefficient ejection. The inadequately emptied ventricle then backs up, with lungs getting filled up and the patient becoming acute accumulation of fluid (rare),the patient comes to emergency in a gasping state with inability to lie down. With mild compromise in heart function, the patient has gradual accumulation of backward congestion and gets mild breathing difficulty, swelling of feet and a dry cough. There is a huge burden of chronic heart failure patients who live a guarded, sometimes apprehensive, life depending on the degree of the normal EF is 55 to 60 percent (depending on age), values less than 40 require special heart failure is a complication post heart attack, but metabolic conditions like uncontrolled diabetes and anatomical distortions like heart valve disease, are also causes. Rarely, viral and severe body infections can also precipitate heart the heart cannot cope with the five litres of fluid in the body, like an overloaded vehicle, one needs to reduce the load and that is why diuretics (urine producing drugs) and fluid and salt restriction, is the order of the patient himself feels the chest lighter with this, coupled with heart rate reducing drugs like beta blockers is only in the last two decades that drugs which help cardiac remodeling (Arni) and cardiac function (gliflozins, GLP analogues, finerinone, verquvo) have emerged and offered better use of this complicated but doable pharmacology (only in trained hands) has revolutionised the life expectancy of chronic heart failure prescription often gets obnoxiously long, for each of these new molecules play their trifling, but important, roles to deliver the patients with certain arrhythmias, a specialised pacemaker is seen to help heart failure. Of course, heart transplant is the ultimate option, but we have 'miles to go before we sleep'.Graduated activity, food supervision and weight reduction are mandatory pillars amid these new pawns which all add to treatment yesterday, regarded as a hopeless case, heart failure is now better understood with the "Sky Force" of new drugs. The recurrent heart "Raid too", can be tamed so that the "Dhadak too" can prosper.(Dr Hemant Thacker is a consultant physician & cardiometabolic specialist practising in Mumbai andJ affiliated to the TOI. Email:dochpt@
